Cite
Supplementary Figures S1-S3 from Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
MLA
Ute M. Moll, et al. Supplementary Figures S1-S3 from Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant P53 in Human Cancer Cells. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....22ceb92bd46b18afed66aa095401e0e2&authtype=sso&custid=ns315887.
APA
Ute M. Moll, Flaminia Talos, Talia Velasco-Hernandez, Victoria Fischer, Ramona Schulz, Natalia D. Marchenko, & Dun Li. (2023). Supplementary Figures S1-S3 from Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells.
Chicago
Ute M. Moll, Flaminia Talos, Talia Velasco-Hernandez, Victoria Fischer, Ramona Schulz, Natalia D. Marchenko, and Dun Li. 2023. “Supplementary Figures S1-S3 from Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant P53 in Human Cancer Cells,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....22ceb92bd46b18afed66aa095401e0e2&authtype=sso&custid=ns315887.